Skip to main content
. 2019 Mar 9;12(5):693–698. doi: 10.1016/j.tranon.2019.02.004

Figure 5.

Figure 5

Diagnostic power evaluated by receiver operating characteristics (ROC) curve analysis for the ability of the four serum COL-6 fragments combined to separate healthy controls from patients with cancer. AUROC, area under the ROC curve.